| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1675221-59-6 | Azilsartan Impurity P;2-(4-((2-ethoxy-7-methoxycarbonylbenzimidazol-1-yl)methyl)phenyl)benzoic acid | C25H22N2O5 |
| 1675248-19-7 | (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanamide | C16H22N6O2 |
| 1676104-73-6 | (4S,5R)-3-((2S,3R)-3-(1,1-Dimethylethoxy)-2-(((9H-fluoren-9-ylmethoxy)carbonyl)amino)-1-oxobutyl)-2,2,5-trimethyl-4-oxazolidinecarboxylicacid | C30H38N2O7 |
| 1676893-24-5 | 2,4-Difluoro-N-(2-methoxy-5-(4-(3-(4-(methylsulfonyl)-1-piperazinyl)-1-propyn-1-yl)-6-quinolinyl)-3-pyridinyl)benzenesulfonamide | C29H27F2N5O5S2 |
| 1677681-05-8 | 1-Benzo(b)thien-4-ylpiperazine hydrochloride (1:2) | C12H14N2S.2(HCl) |
| 1680191-38-1 | 2-Chloro-5-benzothiazolecarboxylic acid ethyl ester | C10H8ClNO2S |
| 1684452-84-3 | Mirabegron Impurity 34;(R)-2-(2-(2-aminothiazol-4-yl)-N-(4-(2-(2-aminothiazol-4-yl)acetamido)phenethyl)acetamido)-1-phenylethyl 2-(2-aminothiazol-4-yl)acetate | C31H32N8O4S3 |
| 1684453-05-1 | Mirabegron Impurity B;(2R)-N-(2-(4-{((2-Amino-1,3-thiazol-4-yl)acetyl)amino}phenyl)ethyl)-2-hydroxy-2-phenylacetamide | C21H22N4O3S |
| 1686100-04-8 | 9-(Biphenyl-4-yl)carbazole-2-boronic acid;B-(9-(1,1'-Biphenyl)-4-yl-9H-carbazol-2-yl)boronic acid | C24H18BNO2 |
| 1686102-84-0 | 4-(4-(Trifluoromethoxy)phenoxy)benzenemethanol;4-(4-(Trifluoromethoxy)phenoxy)benzyl alcohol | C14H11F3O3 |
| 1686124-74-2 | ((3aR,4R,6R,6aR)-6-(4-Amino-2-oxopyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro(3,4-d)(1,3)dioxol-4-yl)methyl Isobutyrate;(4-(4-amino-2-oxopyrimidin-1-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro(3,4-d)(1,3)dioxol-6-yl)methyl 2-methylpropanoate | C16H23N3O6 |
| 1686149-74-5 | 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-(5-methyl-2-oxo-1-piperidinyl)phenyl)-7-oxo-1H-pyrazolo(3,4-c)pyridine-3-carboxamide | C26H27N5O4 |
| 1687736-54-4 | N-6-Isoquinolinyl-N'-(2-oxo-2-(1-pyrrolidinyl)ethyl)urea | C16H18N4O2 |
| 1689542-67-3 | 1-(Phenylsulfonyl)-L-prolyl-4-((5-((aminoiminomethyl)amino)-1-oxopentyl)amino)-L-phenylalanine hydrochloride (1:1) | C26H34N6O6S.HCl |
| 1689576-03-1 | 2-((1,1'-Biphenyl)-3-yl)-4-chloro-6-phenyl-1,3,5-triazine;2-chloro-4-phenyl-6-(3-phenylphenyl)-1,3,5-triazine | C21H14ClN3 |
| 1691249-45-2 | Zanubrutinib;(7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide | C27H29N5O3 |
| 1693758-51-8 | 2-Amino-N-((1S)-1-(1,2-dihydro-8-(2-(1-methyl-1H-pyrazol-4-yl)ethynyl)-1-oxo-2-phenyl-3-isoquinolinyl)ethyl)-pyrazolo(1,5-a)pyrimidine-3-carboxamide;IPI 549 | C30H24N8O2 |
| 1693766-04-9 | 1-(1-(3-Methoxyphenyl)-7-propoxy-3-indolizinyl)ethanone | C20H21NO3 |
| 1694232-96-6 | tert-Butyl (2-(pyridin-3-ylamino)ethyl)carbamate | C12H19N3O2 |
| 1695533-89-1 | 1,5,6,8-Tetrahydro-6-(phenylmethyl)-3-(4-pyridinyl)-7H-pyrazolo(4,3-g)quinazolin-7-one | C21H17N5O |
| 1696392-11-6 | 1-((2'-(Aminocarbonyl)(1,1'-biphenyl)-4-yl)methyl)-2-ethoxy-1H-benzimidazole-7-carboxylic acid | C24H21N3O4 |
| 1696392-12-7 | Azilsartan Impurity Q;(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 3-((4-(2-carbamoylphenyl)phenyl)methyl)-2-ethoxybenzimidazole-4-carboxylate | C29H25N3O7 |
| 1698027-17-6 | 2-Amino-4-bromo-5-chloro-3-fluorobenzoic acid | C7H4BrClFNO2 |
| 1698028-10-2 | 7-Bromo-6-chloro-8-fluoroquinazoline-2,4(1H,3H)-dione | C8H3BrClFN2O2 |
| 1698028-15-7 | Methyl 2-amino-4-bromo-5-chloro-3-fluorobenzoate | C8H6BrClFNO2 |
| 1698293-93-4 | 2-Isopropyl-4-methylpyridin-3-amine | C9H14N2 |
| 1698878-14-6 | 2-Hydroxy-2-methyl-N-(1,2,3,4-tetrahydro-2-(2-(3-pyridinyloxy)acetyl)-6-isoquinolinyl)-1-propanesulfonamide | C20H25N3O5S |
| 1699727-68-8 | (S)-3-Hydroxy-3-cyclopentylpropanenitrile | C8H13NO |
| 1700085-03-5 | Ethyl ((3-chloro-2-pyridinyl)amino)(oxo)acetate | C9H9ClN2O3 |
| 1700265-02-6 | 3-Bromo-2,4-difluoro-1,5-dimethoxybenzene | C8H7BrF2O2 |
| 1700611-18-2 | Tert-butyl cis-3-amino-4-fluoropiperidine-1-carboxylate | C10H19FN2O2 |
| 1700622-06-5 | (3R,4S)-1-(3-Fluorophenyl)-3-((3S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)-2-azetidinone | C24H21F2NO3 |
| 1700622-07-6 | Ezetimibe Desfluoro Methyl Impurity;(3R,4S)-1-(4-Fluorophenyl)-3-((S)-3-hydroxy-3-(P-tolyl)propyl)-4-(4-hydroxyphenyl)azetidin-2-one | C25H24FNO3 |
| 1700622-08-7 | Ezetimibe Desfluoro Chloro Impurity;(3R,4S)-1-(4-Chlorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidine-2-one | C24H21ClFNO3 |
| 1700655-64-6 | Raloxifene Impurity 12;4-(Piperazin-1-yl)benzo(b)thiophene-2-carboxylic acid HCl | C13H15ClN2O2S |
| 1700693-08-8 | morpholinylmethanone | C19H21ClN6O3 |
| 1702259-66-2 | N-(2-((6-((((2,6-Dichloro-3,5-dimethoxyphenyl)amino)carbonyl)methylamino)-4-pyrimidinyl)amino)-5-(4-ethyl-1-piperazinyl)phenyl)-2-propenamide | C29H34Cl2N8O4 |
| 1702271-98-4 | Riociguat Impurity 6;2-(1-((2-fluorophenyl)methyl)pyrazolo(3,4-b)pyridin-3-yl)-5-N-methylpyrimidine-4,5,6-triamine | C18H17FN8 |
| 1702311-34-9 | Josiphos SL-J009-1 Pd G3;Methanesulfonato{(R)-(-)-1-((S)-2-(dicyclohexylphosphino)ferrocenyl)ethyldi-t-butylphosphine}(2'-amino-1,1'-biphenyl-2-yl)palladium(II) | C45H65FeNO3P2PdS |
| 1703755-78-5 | N-Methyl-1,4-dioxaspiro(4.5)decan-8-amine hydrochloride (1:1) | C9H17NO2.HCl |
| 1703793-34-3 | BLU 285;(alphaS)-alpha-(4-Fluorophenyl)-alpha-methyl-2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-yl)-1-piperazinyl)-5-pyrimidinemethanamine | C26H27FN10 |
| 1703794-33-5 | 4-Chloro-6-(1-methyl-1H-pyrazol-4-yl)pyrrolo(2,1-f)(1,2,4)triazine | C10H8ClN5 |
| 1703794-73-3 | Tert-butyl 4-(5-(4-fluorobenzoyl)pyrimidin-2-yl)piperazine-1-carboxylate | C20H23FN4O3 |
| 1706440-47-2 | 5,7-Dichloro-2-methyl-1,2,3,4-tetrahydroquinoline | C10H11Cl2N |
| 1706777-46-9 | Zidebactam sodium;Sodium;((2S,5R)-7-oxo-2-((((3R)-piperidine-3-carbonyl)amino)carbamoyl)-1,6-diazabicyclo(3.2.1)octan-6-yl) sulfate | C13H20N5NaO7S |
| 1707289-21-1 | N-((3S,4S)-3-((6-(2,6-Dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl)amino)tetrahydro-2H-pyran-4-yl)-2-propenamide;N-((3S,4S)-3-((6-(2,6-Dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)tetrahydro-2H-pyran-4-yl)acrylamide | C24H24Cl2N4O4 |
| 1708092-13-0 | Obeticholic Acid Impurity 2;(4R)-4-((3R,5S,6S,7S,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta(a)phenanthren-17-yl)pentanoic acid | C26H44O4 |
| 1708118-13-1 | Everolimus Ring-Opening Impurity;((E,2R,3S,6R)-1-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-2,6,8-trimethyl-5,9-dioxonon-7-en-3-yl) (2S)-1-(2-((2R,3R,6S)-6-((2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxotrideca-3,5,7-trienyl)-2-hydroxy-3-methyloxan-2-yl)-2-oxoacetyl)piperidine-2-carboxylate | C53H83NO14 |
| 1708971-55-4 | Roblitinib;N-(5-Cyano-4-((2-methoxyethyl)amino)-2-pyridinyl)-7-formyl-3,4-dihydro-6-((4-methyl-2-oxo-1-piperazinyl)methyl)-1,8-naphthyridine-1(2H)-carboxamide | C25H30N8O4 |
| 1708971-72-5 | N-(5-Cyano-4-((2-methoxyethyl)amino)-2-pyridinyl)-7-formyl-3,4-dihydro-6-((3-oxo-4-morpholinyl)methyl)-1,8-naphthyridine-1(2H)-carboxamide | C24H27N7O5 |